Safety, tolerability, and effectiveness of repetitive intravenous dihydroergotamine for refractory chronic migraine with cardiovascular risk factors: A retrospective study
CONCLUSION: Patients receiving intravenous DHE by the Jefferson Headache Center inpatient headache protocol had significantly reduced pain severity at discharge. No clinically significant cardiac or electrocardiogram abnormalities were detected in patients with elevated (or low) atherosclerotic cardiovascular disease risk. Repetitive intravenous DHE used by our protocol was safe in refractory chronic migraine patients.PMID:37740562 | DOI:10.1111/head.14636 (Source: Headache)
Source: Headache - September 23, 2023 Category: Neurology Authors: Victor S Wang Justin Kosman Hsiangkuo Yuan Clinton Lauritsen Stephen Shrewsbury Sheena K Aurora Mary Hopkins Stephen Silberstein Source Type: research
Neuropathic changes in corneal nerve endings-A potential objective biomarker for migraine frequency and response to treatment
Headache. 2023 Sep 23. doi: 10.1111/head.14630. Online ahead of print.NO ABSTRACTPMID:37740579 | DOI:10.1111/head.14630 (Source: Headache)
Source: Headache - September 23, 2023 Category: Neurology Authors: Nur Amalina Md Isa Shyam S Tummanapalli Jeremy Chung Bo Chiang Arun V Krishnan Alessandro S Zagami Eric B Papas Maria Markoulli Katherine Spira Source Type: research
Safety, tolerability, and effectiveness of repetitive intravenous dihydroergotamine for refractory chronic migraine with cardiovascular risk factors: A retrospective study
CONCLUSION: Patients receiving intravenous DHE by the Jefferson Headache Center inpatient headache protocol had significantly reduced pain severity at discharge. No clinically significant cardiac or electrocardiogram abnormalities were detected in patients with elevated (or low) atherosclerotic cardiovascular disease risk. Repetitive intravenous DHE used by our protocol was safe in refractory chronic migraine patients.PMID:37740562 | DOI:10.1111/head.14636 (Source: Headache)
Source: Headache - September 23, 2023 Category: Neurology Authors: Victor S Wang Justin Kosman Hsiangkuo Yuan Clinton Lauritsen Stephen Shrewsbury Sheena K Aurora Mary Hopkins Stephen Silberstein Source Type: research
Neuropathic changes in corneal nerve endings-A potential objective biomarker for migraine frequency and response to treatment
Headache. 2023 Sep 23. doi: 10.1111/head.14630. Online ahead of print.NO ABSTRACTPMID:37740579 | DOI:10.1111/head.14630 (Source: Headache)
Source: Headache - September 23, 2023 Category: Neurology Authors: Nur Amalina Md Isa Shyam S Tummanapalli Jeremy Chung Bo Chiang Arun V Krishnan Alessandro S Zagami Eric B Papas Maria Markoulli Katherine Spira Source Type: research
Safety, tolerability, and effectiveness of repetitive intravenous dihydroergotamine for refractory chronic migraine with cardiovascular risk factors: A retrospective study
CONCLUSION: Patients receiving intravenous DHE by the Jefferson Headache Center inpatient headache protocol had significantly reduced pain severity at discharge. No clinically significant cardiac or electrocardiogram abnormalities were detected in patients with elevated (or low) atherosclerotic cardiovascular disease risk. Repetitive intravenous DHE used by our protocol was safe in refractory chronic migraine patients.PMID:37740562 | DOI:10.1111/head.14636 (Source: Headache)
Source: Headache - September 23, 2023 Category: Neurology Authors: Victor S Wang Justin Kosman Hsiangkuo Yuan Clinton Lauritsen Stephen Shrewsbury Sheena K Aurora Mary Hopkins Stephen Silberstein Source Type: research
Neuropathic changes in corneal nerve endings-A potential objective biomarker for migraine frequency and response to treatment
Headache. 2023 Sep 23. doi: 10.1111/head.14630. Online ahead of print.NO ABSTRACTPMID:37740579 | DOI:10.1111/head.14630 (Source: Headache)
Source: Headache - September 23, 2023 Category: Neurology Authors: Nur Amalina Md Isa Shyam S Tummanapalli Jeremy Chung Bo Chiang Arun V Krishnan Alessandro S Zagami Eric B Papas Maria Markoulli Katherine Spira Source Type: research
Safety, tolerability, and effectiveness of repetitive intravenous dihydroergotamine for refractory chronic migraine with cardiovascular risk factors: A retrospective study
CONCLUSION: Patients receiving intravenous DHE by the Jefferson Headache Center inpatient headache protocol had significantly reduced pain severity at discharge. No clinically significant cardiac or electrocardiogram abnormalities were detected in patients with elevated (or low) atherosclerotic cardiovascular disease risk. Repetitive intravenous DHE used by our protocol was safe in refractory chronic migraine patients.PMID:37740562 | DOI:10.1111/head.14636 (Source: Headache)
Source: Headache - September 23, 2023 Category: Neurology Authors: Victor S Wang Justin Kosman Hsiangkuo Yuan Clinton Lauritsen Stephen Shrewsbury Sheena K Aurora Mary Hopkins Stephen Silberstein Source Type: research
Neuropathic changes in corneal nerve endings-A potential objective biomarker for migraine frequency and response to treatment
Headache. 2023 Sep 23. doi: 10.1111/head.14630. Online ahead of print.NO ABSTRACTPMID:37740579 | DOI:10.1111/head.14630 (Source: Headache)
Source: Headache - September 23, 2023 Category: Neurology Authors: Nur Amalina Md Isa Shyam S Tummanapalli Jeremy Chung Bo Chiang Arun V Krishnan Alessandro S Zagami Eric B Papas Maria Markoulli Katherine Spira Source Type: research
Safety, tolerability, and effectiveness of repetitive intravenous dihydroergotamine for refractory chronic migraine with cardiovascular risk factors: A retrospective study
CONCLUSION: Patients receiving intravenous DHE by the Jefferson Headache Center inpatient headache protocol had significantly reduced pain severity at discharge. No clinically significant cardiac or electrocardiogram abnormalities were detected in patients with elevated (or low) atherosclerotic cardiovascular disease risk. Repetitive intravenous DHE used by our protocol was safe in refractory chronic migraine patients.PMID:37740562 | DOI:10.1111/head.14636 (Source: Headache)
Source: Headache - September 23, 2023 Category: Neurology Authors: Victor S Wang Justin Kosman Hsiangkuo Yuan Clinton Lauritsen Stephen Shrewsbury Sheena K Aurora Mary Hopkins Stephen Silberstein Source Type: research
Neuropathic changes in corneal nerve endings-A potential objective biomarker for migraine frequency and response to treatment
Headache. 2023 Sep 23. doi: 10.1111/head.14630. Online ahead of print.NO ABSTRACTPMID:37740579 | DOI:10.1111/head.14630 (Source: Headache)
Source: Headache - September 23, 2023 Category: Neurology Authors: Nur Amalina Md Isa Shyam S Tummanapalli Jeremy Chung Bo Chiang Arun V Krishnan Alessandro S Zagami Eric B Papas Maria Markoulli Katherine Spira Source Type: research
Safety, tolerability, and effectiveness of repetitive intravenous dihydroergotamine for refractory chronic migraine with cardiovascular risk factors: A retrospective study
CONCLUSION: Patients receiving intravenous DHE by the Jefferson Headache Center inpatient headache protocol had significantly reduced pain severity at discharge. No clinically significant cardiac or electrocardiogram abnormalities were detected in patients with elevated (or low) atherosclerotic cardiovascular disease risk. Repetitive intravenous DHE used by our protocol was safe in refractory chronic migraine patients.PMID:37740562 | DOI:10.1111/head.14636 (Source: Headache)
Source: Headache - September 23, 2023 Category: Neurology Authors: Victor S Wang Justin Kosman Hsiangkuo Yuan Clinton Lauritsen Stephen Shrewsbury Sheena K Aurora Mary Hopkins Stephen Silberstein Source Type: research
Neuropathic changes in corneal nerve endings-A potential objective biomarker for migraine frequency and response to treatment
Headache. 2023 Sep 23. doi: 10.1111/head.14630. Online ahead of print.NO ABSTRACTPMID:37740579 | DOI:10.1111/head.14630 (Source: Headache)
Source: Headache - September 23, 2023 Category: Neurology Authors: Nur Amalina Md Isa Shyam S Tummanapalli Jeremy Chung Bo Chiang Arun V Krishnan Alessandro S Zagami Eric B Papas Maria Markoulli Katherine Spira Source Type: research
Changes in cognitive appraisal in a randomized controlled trial of mindfulness-based cognitive therapy for patients with migraine
CONCLUSION: In this study, pain catastrophizing showed strong promise as a potential mechanism of MBCT-M. Future research should continue to explore cognitive appraisal changes in mindfulness-based interventions.PMID:37723970 | DOI:10.1111/head.14627 (Source: Headache)
Source: Headache - September 19, 2023 Category: Neurology Authors: Jessica A Kruse Elizabeth K Seng Source Type: research
Correction to "Regional cerebral perfusion during the premonitory phase of triggered migraine: A double-blind randomized placebo-controlled functional imaging study using pseudo-continuous arterial spin labelling"
Headache. 2023 Sep;63(8):1199. doi: 10.1111/head.14610.NO ABSTRACTPMID:37723989 | DOI:10.1111/head.14610 (Source: Headache)
Source: Headache - September 19, 2023 Category: Neurology Source Type: research
Correction to "A causative role for remote dural puncture and resultant arachnoid bleb in new daily persistent headache: A case report"
Headache. 2023 Sep;63(8):1198. doi: 10.1111/head.14609.NO ABSTRACTPMID:37723990 | DOI:10.1111/head.14609 (Source: Headache)
Source: Headache - September 19, 2023 Category: Neurology Source Type: research
